|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
208,280,000 |
Market
Cap: |
1.95(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.09 - $15.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
27 |
Total Shares Sold |
567,946 |
1,097,598 |
2,193,115 |
3,020,700 |
Total Sell Value |
$5,420,056 |
$10,572,222 |
$21,602,157 |
$28,825,014 |
Total People Sold |
4 |
7 |
8 |
8 |
Total Sell Transactions |
23 |
46 |
97 |
149 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Virani Shafique |
Chief Business Officer |
|
2023-02-16 |
4 |
AS |
$8.42 |
$14,887 |
D/D |
(1,768) |
187,332 |
|
-3% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-16 |
4 |
B |
$7.90 |
$337,043 |
I/I |
42,682 |
12,447,200 |
1.5 |
-3% |
|
Virani Shafique |
Chief Business Officer |
|
2023-02-15 |
4 |
D |
$8.44 |
$6,296 |
D/D |
(746) |
189,100 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2023-02-15 |
4 |
AS |
$8.33 |
$62,358 |
D/D |
(7,486) |
189,846 |
|
-12% |
|
Virani Shafique |
Chief Business Officer |
|
2023-02-15 |
4 |
OE |
$2.22 |
$16,619 |
D/D |
7,486 |
197,332 |
|
- |
|
Secora Michael |
Chief Financial Officer |
|
2023-02-15 |
4 |
D |
$8.44 |
$10,618 |
D/D |
(1,258) |
794,310 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-15 |
4 |
D |
$8.44 |
$11,360 |
D/D |
(1,346) |
940,927 |
|
- |
|
Larson Tina Marriott |
President and COO |
|
2023-02-15 |
4 |
D |
$8.44 |
$13,529 |
D/D |
(1,603) |
427,844 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-14 |
4 |
B |
$7.95 |
$50,060 |
I/I |
6,300 |
12,404,518 |
1.5 |
-12% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-13 |
4 |
B |
$7.97 |
$258,837 |
I/I |
32,474 |
12,398,218 |
1.5 |
-8% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-10 |
4 |
B |
$7.98 |
$87,808 |
I/I |
11,000 |
12,365,744 |
1.5 |
-6% |
|
Borgeson Blake |
Director |
|
2023-02-07 |
4 |
AS |
$8.81 |
$78,263 |
D/D |
(8,885) |
7,602,942 |
|
1% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
963,710 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
966,710 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-02 |
4 |
AS |
$9.20 |
$23,013 |
I/I |
(2,500) |
0 |
|
6% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-02 |
4 |
AS |
$9.22 |
$170,548 |
D/D |
(18,500) |
942,273 |
|
6% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
960,773 |
|
- |
|
Larson Tina Marriott |
President and COO |
|
2023-02-01 |
4 |
D |
$8.55 |
$26,445 |
D/D |
(3,093) |
429,447 |
|
- |
|
Larson Tina Marriott |
President and COO |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
226,793 |
432,540 |
|
- |
|
Secora Michael |
Chief Financial Officer |
|
2023-02-01 |
4 |
D |
$8.55 |
$22,820 |
D/D |
(2,669) |
795,568 |
|
- |
|
Secora Michael |
Chief Financial Officer |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
210,163 |
798,237 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-01 |
4 |
D |
$8.55 |
$11,816 |
D/D |
(1,382) |
942,273 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
417,850 |
943,655 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2023-02-01 |
4 |
D |
$8.55 |
$25,599 |
D/D |
(2,994) |
189,846 |
|
- |
|
628 Records found
|
|
Page 12 of 26 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|